{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T13:10:08Z","timestamp":1756732208519,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"DOI":"10.7759\/cureus.91401","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:43:46Z","timestamp":1756730626000},"source":"Crossref","is-referenced-by-count":0,"title":["The Rarest Subtype of Plasma Cell Dyscrasia: IgE Multiple Myeloma"],"prefix":"10.7759","author":[{"given":"Nora","family":"El Maachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soukaina","family":"Haidouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoufal","family":"Benlachgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belkhayat","family":"Aziza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoubida","family":"Tazi Mezalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2021-0087","article-title":"IgE multiple myeloma: detection and follow-up","volume":"3","author":"Nafr\u00eda Jim\u00e9nez B","year":"2022","unstructured":"Nafr\u00eda Jim\u00e9nez B, Oliveros Conejero R. IgE multiple myeloma: detection and follow-up. Adv Lab Med. 2022, 3:79-90. 10.1515\/almed-2021-0087","journal-title":"Adv Lab Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2021.1929443","article-title":"A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female","volume":"81","author":"Fager Ferrari M","year":"2021","unstructured":"Fager Ferrari M, Lemonakis K, F\u00f6rnvik Jonsson M. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female. Scand J Clin Lab Invest. 2021, 81:385-8. 10.1080\/00365513.2021.1929443","journal-title":"Scand J Clin Lab Invest"},{"key":"ref3","article-title":"IgD and IgE variants of myeloma: valuable insights and therapeutic opportunities","volume":"27","author":"Richardson PG","year":"2013","unstructured":"Richardson PG, Laubach J, Paba-Prada C, Anderson KC. IgD and IgE variants of myeloma: valuable insights and therapeutic opportunities. Oncology (Williston Park). 2013, 27:803-4, 806.","journal-title":"Oncology (Williston Park)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/4747989","article-title":"IgE plasma cell leukemia harboring t(11;14) and 1q amplification","volume":"2023","author":"Nakahara W","year":"2023","unstructured":"Nakahara W, Ogawa T, Matsunaga H, et al.. IgE plasma cell leukemia harboring t(11;14) and 1q amplification. Case Rep Hematol. 2023, 2023:4747989. 10.1155\/2023\/4747989","journal-title":"Case Rep Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25209","article-title":"Clinical characteristics and treatment outcomes in IgE multiple myeloma: a case-control study","volume":"93","author":"Jurczyszyn A","year":"2018","unstructured":"Jurczyszyn A, Castillo JJ, Vesole DH, et al.. Clinical characteristics and treatment outcomes in IgE multiple myeloma: a case-control study. Am J Hematol. 2018, 93:E238-41. 10.1002\/ajh.25209","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.15761\/HMO.1000155","article-title":"Unusual case of IgE multiple myeloma: case report","volume":"3","author":"Mani M","year":"2018","unstructured":"Mani M, Fan W, Hawkins K. Unusual case of IgE multiple myeloma: case report. Hematol Med Oncol.  2018, 3:1-3. 10.15761\/HMO.1000155","journal-title":"Hematol Med Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005815","article-title":"IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells","volume":"10","author":"Kehl N","year":"2022","unstructured":"Kehl N, Kilian M, Michel J, et al.. IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells. J Immunother Cancer. 2022, 10:e005815. 10.1136\/jitc-2022-005815","journal-title":"J Immunother Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2436","article-title":"Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants","volume":"101","author":"Avet-Loiseau H","year":"2003","unstructured":"Avet-Loiseau H, Garand R, Lod\u00e9 L, Harousseau JL, Bataille R. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003, 101:1570-1. 10.1182\/blood-2002-08-2436","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-3-32","article-title":"Prozone effect of serum IgE levels in a case of plasma cell leukemia","volume":"3","author":"Talamo G","year":"2010","unstructured":"Talamo G, Castellani W, Dolloff NG. Prozone effect of serum IgE levels in a case of plasma cell leukemia. J Hematol Oncol. 2010, 3:32. 10.1186\/1756-8722-3-32","journal-title":"J Hematol Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00807-9","article-title":"Multiple myeloma with t(11;14): impact of novel agents on outcome","volume":"13","author":"Puertas B","year":"2023","unstructured":"Puertas B, Gonz\u00e1lez-Calle V, Sobejano-Fuertes E, et al.. Multiple myeloma with t(11;14): impact of novel agents on outcome. Blood Cancer J. 2023, 13:40. 10.1038\/s41408-023-00807-9","journal-title":"Blood Cancer J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.07.008","article-title":"A rare and unique case of aggressive IgE-\u03bb plasma cell myeloma in a 28-year-old woman presented initially as an orbital mass","volume":"43","author":"Li K","year":"2012","unstructured":"Li K, Ku G, Yan M, Broome HE, Kelner M, Wang HY. A rare and unique case of aggressive IgE-\u03bb plasma cell myeloma in a 28-year-old woman presented initially as an orbital mass. Hum Pathol. 2012, 43:2376-84. 10.1016\/j.humpath.2012.07.008","journal-title":"Hum Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11553-3","article-title":"Efficacy and safety of venetoclax in patients with relapsed\/refractory multiple myeloma: a meta-analysis","volume":"23","author":"Gao X","year":"2023","unstructured":"Gao X, Zeng H, Zhao X, et al.. Efficacy and safety of venetoclax in patients with relapsed\/refractory multiple myeloma: a meta-analysis. BMC Cancer. 2023, 23:1058. 10.1186\/s12885-023-11553-3","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18243","article-title":"How do we manage t(11;14) plasma cell disorders with venetoclax?","volume":"199","author":"Chakraborty R","year":"2022","unstructured":"Chakraborty R, Bhutani D, Lentzsch S. How do we manage t(11;14) plasma cell disorders with venetoclax?. Br J Haematol. 2022, 199:31-9. 10.1111\/bjh.18243","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388938-the-rarest-subtype-of-plasma-cell-dyscrasia-ige-multiple-myeloma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:43:47Z","timestamp":1756730627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388938-the-rarest-subtype-of-plasma-cell-dyscrasia-ige-multiple-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.91401","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}